Bandingkan Harga & Kinerja Adiwarna Anugerah Abadi Tbk. (NAIK) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Adiwarna Anugerah Abadi Tbk. dan Organon Pharma Indonesia Tbk.: Adiwarna Anugerah Abadi Tbk. diperdagangkan di Rp93 (kapitalisasi pasar 309,64 M, volume 24 jam 4,14 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Adiwarna Anugerah Abadi Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| NAIK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 309,64 M | 104,4 M |
Volume | 4,14 jt | — |
Lot | 41,38 rb | — |
Perputaran | 379,12 jt | — |
Harga Rata-rata | 91,63 | — |
Nilai Transaksi | 379,12 jt | — |
Harga Ekuilibrium Indikatif | 93 | — |
Volume Ekuilibrium Indikatif | 591 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Adiwarna Anugerah Abadi Tbk.
PT Adiwarna Anugerah Abadi Tbk was established based on Deed of notary Rony Saputra Sudarmo, SH., No.4 dated 8 May 2007. The Company started its commercial operations in 2007. The Company parent entity is PT Adiwarna Anugerah Investama. Mr. Johannes and Mrs. Ernawati is the final controller of the Company.
Selengkapnya di halaman NAIK →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
